Key Market Indicators
The Slovene blood and blood forming organs medicine market is set to reach $85 million by 2026. This is a 2.6% annual growth from $72.1 million in 2021. Since 2012, the Slovene market has increased by 10.2% each year. Mexico overtook Slovenia in 2021 to become the 23rd largest market. Germany, Italy, and South Korea respectively ranked second, third, and fourth. Meanwhile, hospital discharges for anemia in Slovenia are predicted to reach 1,780 by 2026, a decline of 0.8% year-on-year. Since 2002, demand has decreased by 2.5% each year. New Zealand overtook Slovenia in 2021 to become the 28th largest market. Germany, the United Kingdom, and Poland respectively ranked second, third, and fourth.
